Benin Management Corp Amgen Inc Transaction History

Benin Management Corp

$349 Million
Q1 2025

A detailed history of Benin Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Benin Management Corp holds 1,126 shares of AMGN stock, worth $350,805. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,126

Previous 1,111 1.35%

Holding current value

$350,805

Previous $289,000 21.11%

% of portfolio

0.1%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$258.59 - $327.36 $3,878 - $4,910	15 Added 1.35%	1,126 $350,000
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $2,475 - $2,699	-8 Reduced 0.71%	1,111 $357,000
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $28,377 - $34,485	108 Added 10.68%	1,119 $349,000
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $2,419 - $2,921	9 Added 0.9%	1,011 $287,000
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $1,789 - $2,019	7 Added 0.7%	1,002 $288,000
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $217,556 - $270,102	995 New	995 $267,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $191,921 - $233,920	850 New	850 $205,000
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $657,754 - $731,965	-2,851 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $21,927 - $24,257	-100 Reduced 3.39%	2,851 $689,000
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $233,087 - $266,747	1,172 Added 65.88%	2,951 $664,000
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $212 - $248	-1 Reduced 0.06%	1,779 $378,000
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $2,335 - $2,591	-10 Reduced 0.56%	1,780 $434,000
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $22,191 - $25,860	-100 Reduced 5.29%	1,790 $445,000
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $5,866 - $6,523	-25 Reduced 1.31%	1,890 $480,000
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 2.54%	1,915 $452,000
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $27,336 - $36,255	-150 Reduced 7.09%	1,965 $398,000
Q4 2019 Jan 23, 2020	SELL	$189.21 - $243.2 $3,784 - $4,864	-20 Reduced 0.94%	2,115 $510,000
Q3 2019 Oct 22, 2019	SELL	$174.11 - $208.62 $43,527 - $52,155	-250 Reduced 10.48%	2,135 $413,000
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $22,300 - $26,031	-125 Reduced 4.98%	2,385 $464,000
Q3 2018 Oct 17, 2018	SELL	$185.29 - $208.89 $3,705 - $4,177	-20 Reduced 0.79%	2,510 $520,000
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $237,202 - $277,200	-1,400 Reduced 35.62%	2,530 $431,000
Q4 2017 Jan 18, 2018	SELL	$168.79 - $188.59 $14,347 - $16,030	-85 Reduced 2.12%	3,930 $683,000
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $671,669 - $766,865	4,015	4,015 $749,000

Others Institutions Holding AMGN

# of Institutions

3,203

Shares Held

422M

Call Options Held

7.05M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.

Account

Benin Management Corp Amgen Inc Transaction History